Please use this identifier to cite or link to this item:
Title: Established, emerging and future roles of PET/CT in the management of colorectal cancer.
Austin Authors: Herbertson, R A;Scarsbrook, A F;Lee, S T;Tebbutt, Niall C ;Scott, Andrew M 
Ludwig Institute for Cancer Research, Melbourne Centre for Clinical Sciences, Austin Health, Heidelberg, Victoria, Australia
Issue Date: 23-Oct-2008
Publication information: Clinical Radiology 2008; 64(3): 225-37
Abstract: Positron-emission tomography-computed tomography (PET/CT) is rapidly being integrated into the imaging pathways of several different tumour types, most frequently using the glucose analogue 2- [(18)F]-fluoro-2-deoxy-D-glucose (FDG). Integrated FDG-PET/CT combines functional and anatomical imaging to improve sensitivity and specificity of tumour detection. The aim of this article is to review the established, emerging, and future roles of FDG-PET/CT in the management of patients with colorectal cancer (CRC).
Gov't Doc #: 19185652
DOI: 10.1016/j.crad.2008.08.008
Type: Journal Article
Subjects: Colonoscopy
Colorectal Neoplasms.drug therapy.radionuclide imaging
Cost-Benefit Analysis
Fluorodeoxyglucose F18.diagnostic use
Great Britain
Neoplasm Recurrence, Local.radionuclide imaging
Neoplasm Staging
Neoplasm, Residual
Positron-Emission Tomography.economics.methods.trends
Radiopharmaceuticals.diagnostic use
Radiotherapy Planning, Computer-Assisted
Sensitivity and Specificity
Tomography, X-Ray Computed.economics.methods.trends
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Dec 2, 2022

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.